Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 22;1:11. doi: 10.1038/s44276-023-00012-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — a Prevalence of human papillomavirus (HPV) infection grouped by risk among low- and high-grade squamous intraepithelial lesion (LSIL and HSIL, respectively). ***p < 0.01 (based on the comparison on the prevalence of oncogenic HPV types in LSIL individuals with those in HSIL individuals). b Prevalence of different HPV types grouped by risk among HSIL subgroups. HPV human papillomavirus, HSIL high-grade squamous intraepithelial lesion, HPVneg HPV negative, non_oHPV non-oncogenic HPV, pro_oHPV probably oncogenic HPV, oHPV oncogenic HPV, Mod Moderate dysplasia, Mod/CiS moderate dysplasia and Cancer in situ, and CiS Cancer in situ.